Patents Assigned to ADITECH PHARMA AB
  • NOVEL GLUCOPYRANOSE ESTERS AND GLUCOFURANOSE ESTERS OF ALKYL- FUMARATES AND THEIR PHARMACEUTICAL USE
    Publication number: 20100144651
    Abstract: The present invention relates to novel glucofuranose esters and glucopyranose esters of alkyl-fumarates. The esters are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.
    Type: Application
    Filed: July 7, 2006
    Publication date: June 10, 2010
    Applicant: ADITECH PHARMA AB
    Inventors: Henrik Nilsson, Jens E.T. Andersen
  • CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
    Publication number: 20090304790
    Abstract: The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designated to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects.
    Type: Application
    Filed: October 7, 2005
    Publication date: December 10, 2009
    Applicant: ADITECH PHARMA AB
    Inventors: Henrik Nilsson, Florian Schoenharting, Bernd W. Mueller, Joseph R. Robinson, Bonna Robinson
  • Combination Therapy with Fumaric Acid Esters for the Treatment of Autoimmune and/or Inflammatory Disorders
    Publication number: 20080300217
    Abstract: The present invention relates to compositions, kits and methods for administration of a first component of fumaric acid ester(s), or a pharmaceutically acceptable salt thereof, and a second component which is a substance that reduces or eliminates flushing.
    Type: Application
    Filed: October 9, 2006
    Publication date: December 4, 2008
    Applicant: ADITECH PHARMA AB
    Inventor: Henrik Nilsson
  • Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
    Publication number: 20080299196
    Abstract: The present invention relates to controlled release pharmaceutical compositions comprising fumaric acid ester(s) as active substance(s). The compositions are suitable for use in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders and are designed to release the fumaric acid ester in a controlled manner so that local high concentrations of the active substance within the gastrointestinal tract upon oral administration can be avoided and, thereby, enabling a reduction in gastro-intestinal related side-effects.
    Type: Application
    Filed: October 6, 2006
    Publication date: December 4, 2008
    Applicant: Aditech Pharma AB
    Inventors: Henrik Nilsson, Bernd W. Muller
  • Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
    Publication number: 20080227847
    Abstract: The present invention relates to novel amino acid salts of fumaric acid monoalkylesters. The salts are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders.
    Type: Application
    Filed: July 7, 2006
    Publication date: September 18, 2008
    Applicant: ADITECH PHARMA AB
    Inventors: Henrik Nilsson, Jens E.T. Andersen, Bernd W. Mueller
  • Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
    Publication number: 20080004344
    Abstract: The present invention relates to novel strontium salts of fumaric acid monoalkylesters. The salts are suitable for use as active substances in the treatment of e.g.
    Type: Application
    Filed: November 9, 2005
    Publication date: January 3, 2008
    Applicant: ADITECH PHARMA AB
    Inventors: Henrik Nilsson, Jens Andersen, Bernd Mueller, Joseph Robinson, Bonna Robinson